Quarterly report pursuant to Section 13 or 15(d)

Commitments (Details)

Commitments (Details)
7 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
Commitments (Details) [Line Items]  
Underwriting discount, description The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 1,650,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions.
Over-Allotment Option [Member] | Underwriting Agreement [Member]  
Commitments (Details) [Line Items]  
Fee per unit | $ / shares $ 0.35
Underwriting fees $ 3,850,000
Deferred fee $ 4,427,500
Chardan Capital Markets, LLC [Member]  
Commitments (Details) [Line Items]  
Business combination related description the Company granted Chardan Capital Markets, LLC, for a period of 15 months after the date of the consummation of a Business Combination, a right of first refusal to act as lead underwriters or minimally as a co-manager, with at least 30% of the economics; or, in the case of a three-handed deal 20% of the economics, for any and all future public and private equity and debt offerings. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of the Initial Public Offering.
Anchor Investor [Member]  
Commitments (Details) [Line Items]  
Other commitments, description In connection with the closing of the Initial Public Offering, certain qualified institutional buyers or institutional accredited investors not affiliated with any member of the Company’s management (the “anchor investors”) purchased an aggregate of 10,370,000 Units. Separately, each of the anchor investors entered into a separate agreement with the Sponsor pursuant to which such investors purchased membership interests in the Sponsor representing indirect beneficial interests in up to 60,500 Founder Shares and 224,490 Private Placement Warrants upon closing of the Initial Public Offering (or up to 69,575 Founder Shares and 244,694 Private Placement Warrants if the underwriters’ over-allotment option is exercised in full).